V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250000106 | 250007223 | null | null | null | null | 2020-05-12 | null | null | N | TRIAL UNSPECIFIED | 101580077 |
| 250000218 | 250007225 | null | null | Palliative (P) | 2018-10-24 | 2018-11-07 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | ECX | 101444568 |
| 250000331 | 250007227 | 1.59 | 54.35 | null | 2018-08-20 | 2018-08-27 | WT Guidelines Cyclophos/Doxorubicin | 02 | N | OLARATUMAB | 101320011 |
| 250000648 | 250007231 | 1.63 | 131.8 | null | null | 2018-05-31 | PEMBROLIZUMAB + PEMETREXED | 01 | null | CARBOPLATIN + PEMETREXED | 100068845 |
| 250000752 | 250007234 | 0 | 60 | Palliative (P) | 2019-10-08 | 2020-01-05 | Pemetrexed | 02 | Y | AVELUMAB | 100655978 |
| 250000823 | 250007239 | null | null | Palliative (P) | 2020-01-30 | 2020-01-30 | null | 02 | null | PACLITAXEL | 100791807 |
| 250000920 | 250007241 | 1.83 | 53.7 | null | 2018-07-08 | 2018-09-27 | ECX | 02 | null | CARBOPLATIN + PACLITAXEL | 100989360 |
| 250001052 | 250007243 | null | null | null | 2020-08-02 | 2020-08-11 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101706684 |
| 250001074 | 250007246 | 1.82 | 14.9 | Neo-adjuvant (N) | 2017-09-02 | 2017-09-10 | DOXORUBICIN | 02 | N | WT SIOP 2002 01 POST OP CARBO, ETOP | 100864065 |
| 250001092 | 250007248 | 1.8 | null | Curative (C) | 2020-01-29 | 2020-02-05 | AXITINIB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100809939 |
| 250001115 | 250007249 | 1.94 | 67 | null | 2020-01-21 | 2020-06-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | NB HRNBL-1 ISOTRETINOIN | 101513283 |
| 250001131 | 250007250 | 1.05 | 65.5 | Neo-adjuvant (N) | null | 2019-08-14 | TIP | 02 | N | LIPOSOMAL DOXORUBICIN | 100206432 |
| 250001134 | 250007251 | 1.76 | 64.3 | Palliative (P) | null | 2018-09-09 | CISPLATIN + VINORELBINE | 2 | null | CABOZANTINIB | 100538026 |
| 250001208 | 250007253 | null | null | Palliative (P) | null | 2019-10-04 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | CAPECITABINE + IRINOTECAN | 101544258 |
| 250001331 | 250007256 | null | null | null | 2021-06-07 | 2021-06-07 | ETOPOSIDE | 01 | null | DOXORUBICIN | 100604720 |
| 250001358 | 250007257 | 1.77 | 61.9 | null | 2019-06-03 | 2019-06-03 | null | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100992873 |
| 250001584 | 250007260 | 1.87 | 19.5 | Adjuvant (A) | 2018-07-17 | 2019-02-27 | Cisplatin | 02 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 100910112 |
| 250001605 | 250007261 | null | null | null | 2020-02-12 | 2020-03-10 | null | 02 | null | GEMCITABINE | 101745907 |
| 250001607 | 250007262 | null | null | null | 2021-06-02 | 2021-06-02 | IVADo | N | N | CAPECITABINE + CARBOPLATIN | 100796180 |
| 250001610 | 250007263 | null | null | null | null | 2021-06-24 | AVAPRITINIB | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 100857543 |
| 250001632 | 250007264 | 1.68 | 58.6 | Curative (C) | 2019-11-05 | 2020-02-19 | Carboplatin AUC 2 - 5 | 02 | null | DOCETAXEL | 101058742 |
| 250001677 | 250007266 | 1.78 | 67.85 | Palliative (P) | null | 2020-01-07 | Carboplatin + Docetaxel | 02 | N | CARBOPLATIN + DOCETAXEL | 100034115 |
| 250001697 | 250007268 | 1.74 | 0 | null | 2019-03-16 | 2019-12-21 | Tivozanib | 02 | N | EVEROLIMUS + LENVATINIB | 101840571 |
| 250001761 | 250007269 | null | null | null | null | 2018-05-17 | NB HRNBL-1 BUMEL MAT | null | null | IPILIMUMAB + NIVOLUMAB | 100399430 |
| 250001793 | 250007270 | 1.68 | 69.4 | null | 2019-08-25 | 2019-09-16 | STS Rhabdomyosarcoma RMS 2005 IVA | 01 | N | IRINOTECAN + TEMOZOLOMIDE | 100602541 |
| 250001811 | 250007271 | null | null | Palliative (P) | null | 2020-09-29 | DOXORUBICIN | null | N | ATEZOLIZUMAB | 100389389 |
| 250001892 | 250007272 | 1.59 | 76.2 | Palliative (P) | 2019-03-11 | 2019-04-27 | null | 02 | N | RUCAPARIB | 101074705 |
| 250002280 | 250007278 | 1.85 | 13 | null | 2016-11-04 | 2016-11-14 | Fluorouricil + Folonic Acid (MdG) | 02 | N | TRIAL UNSPECIFIED | 100171267 |
| 250002352 | 250007279 | 1.73 | 80.6 | Palliative (P) | 2019-01-15 | 2019-01-15 | Sunitinib | 02 | null | CARBOPLATIN + FLUOROURACIL | 100092336 |
| 250001320 | 250007283 | null | null | null | null | 2017-01-28 | Rucaparib | null | null | TRABECTEDIN | 100015616 |
| 250001761 | 250007285 | 0 | 101.8 | null | 2017-10-18 | 2018-06-04 | null | 02 | null | PANITUMUMAB | 100399430 |
| 250001986 | 250007286 | null | null | Palliative (P) | 2018-09-04 | 2018-09-07 | null | 02 | N | CARBOPLATIN | 100407895 |
| 250002073 | 250007287 | null | null | Palliative (P) | 2019-04-10 | 2019-10-13 | CARBOPLATIN + PACLITAXEL | 01 | N | CAPECITABINE + RT | 101020099 |
| 250002512 | 250007288 | 1.75 | 9.9 | Adjuvant (A) | 2019-08-12 | 2019-08-27 | Dinutuximab Beta | 01 | N | CAPECITABINE + OXALIPLATIN | 101653937 |
| 250001198 | 250007513 | 1.72 | null | null | null | 2019-08-02 | null | null | null | CISPLATIN + GEMCITABINE | 101492638 |
| 250001210 | 250007515 | 0 | null | Palliative (P) | 2018-12-15 | 2020-01-26 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100089851 |
| 250001212 | 250007516 | 1.61 | 41.7 | null | null | 2019-09-21 | null | null | null | CARBOPLATIN + GEMCITABINE | 101252895 |
| 250001213 | 250007517 | 1.8 | 56 | null | null | 2018-09-09 | NIVOLUMAB | null | null | NIVOLUMAB | 101142963 |
| 250001216 | 250007518 | 1.85 | null | Palliative (P) | 2022-01-17 | 2022-01-30 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101166125 |
| 250001217 | 250007519 | 1.84 | 70.8 | Neo-adjuvant (N) | null | 2017-12-20 | NIVOLUMAB | null | N | NIVOLUMAB | 101059137 |
| 250001218 | 250007520 | 1.66 | 77 | null | null | 2017-09-22 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 100062941 |
| 250001222 | 250007521 | 1.66 | 90.6 | null | null | 2015-04-24 | null | null | null | CARBOPLATIN + GEMCITABINE | 101336301 |
| 250001223 | 250007522 | 1.6 | 61.6 | null | null | 2020-05-04 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 101577528 |
| 250001230 | 250007525 | 1.69 | 74.9 | Palliative (P) | 2019-05-08 | 2019-05-09 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100881688 |
| 250001247 | 250007527 | 1.78 | 85.6 | Palliative (P) | 2020-03-26 | 2020-03-26 | null | 02 | N | PEMBROLIZUMAB | 101300162 |
| 250001250 | 250007529 | 1.67 | 54.3 | null | null | 2021-02-10 | null | null | null | CARBOPLATIN + GEMCITABINE | 101204830 |
| 250001256 | 250007530 | 1.79 | 75 | null | null | 2019-10-10 | null | null | null | CARBOPLATIN + GEMCITABINE | 100593119 |
| 250001257 | 250007531 | 1.71 | null | null | null | 2017-11-04 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100936459 |
| 250001262 | 250007532 | 1.88 | 84.8 | Adjuvant (A) | 2020-08-29 | 2020-09-15 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101115459 |
| 250001273 | 250007534 | 1.63 | 85.15 | Palliative (P) | 2020-09-05 | 2020-09-09 | null | 02 | N | CISPLATIN + GEMCITABINE | 100844679 |